Breaking News, Financial News

Financial Report: Abbott 4Q

Worldwide pharmaceutical sales were up 5% to $4.8 billion in the quarter.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 4Q 4Q Revenues: $8.8 billion (+11%) 4Q Earnings: $1.5 million (flat) FY Revenues: $30.7 billion (+4%) FY Revenues: 5.7 billion (+18%) Comments: Worldwide pharmaceutical sales were up 5% to $4.8 billion in the quarter. International Pharmaceutical sales accounted for $2.5 billion and U.S. sales, $2.3 billion. Humira sales were $1.7 billion (+23%) and Niaspan sales were up 15% to $254 million. TriCor/Trilipix sales were $419 million (-8%). Kaletra sales were flat at $378 mil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters